Priporočila za preprečevanje in zdravljenje slabosti in bruhanja ob sistemskem onkološkem zdravljenju

Show document
A+ | A- | | SLO | ENG

Title:	Priporočila za preprečevanje in zdravljenje slabosti in bruhanja ob sistemskem onkološkem zdravljenju
Authors:	ID Reberšek, Martina (Author) ID Hribernik, Nežka (Author)
Files:	PDF - Presentation file, download (433,68 KB) MD5: 8F65EBF15E64B54C7378F4521AF74245 PID: 20.500.12556/dirros/887fa148-a6cf-4122-81b9-32c2fdf87839
Language:	Slovenian
Typology:	1.04 - Professional Article
Organization:	OI - Institute of Oncology
Abstract:	Slabost in bruhanje ostajata kljub velikemu napredku najpogostejša neželena učinka sistemskega zdravljenja, ki bistveno zmanjšata bolnikovo kvaliteto življenja in zmanjšata njegovo komplianco za nadaljevanje sistemskega zdravljenja. Priporočila za preprečevanje in zdravljenje slabosti in bruhanja zaradi zdravljenja s citostatiki so bila objavljena leta 2003 v reviji Onkologija. S tem prispevkom dopolnjujemo priporočila za obravnavo slabosti in bruhanja z novostmi, ki so bila objavljena v NCCN smernicah leta 2014 in MASCC in ESMO leta 2010 (1,2).
Keywords:	slabost, bruhanje, onkološki bolniki, sistemsko zdravljenje
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2014
Number of pages:	str. 105-107, 119
Numbering:	Letn. 18, št. 2
PID:	20.500.12556/DiRROS-9135
UDC:	616-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-QSP273HS
COBISS.SI-ID:	1964155
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	4154
Downloads:	877
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Recommendations for prevention and treatment of nausea and vomiting in systemic oncology treatment
Abstract:	In spite of great advancement, nausea and vomiting remain the most common undesirable effects of systemic cancer treatment, which substantially lower the patients’ quality of life and reduce their compliance to continue systemic treatment. Recommendations for prevention and treatment of nausea and vomiting resulting from cytostatic treatment were published in 2003 in Oncology magazine. This article complements the recommendations for treatment of nausea and vomiting with new developments, which were published in the NCCN guidelines in 2014 and MASCC and ESMO in 2010 (1, 2). We present our method for treating dysphagia with the help of intraluminal oesophageal stents. In our practice, the intraluminal oesophageal stent has proven to be a very effective and the most patient-friendly method for optimal delivery of nutrients before and during neoadjuvant therapy. There are few complications, and insertions do not have a negative impact on the perioperative outcomes.